ArticlePulmonary circulation2026

Sotatercept as a Therapeutic Option for Systemic Sclerosis-Associated Pulmonary Arterial Hypertension With Features of PVOD/PCH.

Yujin Nishioka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.